ProCE Banner Series

Integrating New Data From IAS 2023 – Pharmacist Perspectives

Join 2 pharmacist experts for an interactive webinar focused on the most clinically relevant data presented at IAS 2023, as well as other key studies that may be significant to the advancement of HIV patient care.  Case vignettes will be used to explore integration of findings into everyday patient management.

  ACPE
Who Should Attend

This program is intended for pharmacists, and other healthcare professionals who provide care for patients with or at risk of HIV infection.

All Events

Integrating New Data From IAS 2023 – Pharmacist Perspectives

Past Events

August

03

2023

1:00 PM - 2:00 PM Eastern Time (ET)

Virtual

August

17

2023

1:00 PM - 2:00 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Brooke Bates, PharmD, BCPS, AAHIVP

Specialty Pharmacy Clinical Manager
Pediatric HIV Clinical Pharmacist
Indiana University Health
Indianapolis, Indiana

ProCE Banner Faculty
Neha Sheth Pandit, PharmD, AAHIVP, BCPS

Professor
Vice Chair for Research and Scholarship
Department of Practice, Sciences, and Health Outcomes Research
School of Pharmacy
University of Maryland
Clinical Pharmacist
THRIVE Program
Baltimore, Maryland

Topics

The timing and agenda for each webinar is as follows:

  • Introduction and Program Overview
  • Key Findings From IAS 2023
  • Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens. 

Target Audience
This program is intended for pharmacists, and other healthcare professionals who provide care for patients with or at risk of HIV infection. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents
  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens
  • Integrate the latest scientific findings to develop and optimize effective HIV prevention strategies

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC, and the American Academy of HIV Medicine. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-9999-23-099-L02-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

In partnership with American Academy of HIV Medicine.

Supported by an educational grant from ViiVHealthcare.